loading page

Using Wearables to Manage Atrial Fibrillation: Pushing the Boundaries with Consumer Devices
  • Marco Perez
Marco Perez
Stanford University

Corresponding Author:[email protected]

Author Profile


The irregular pulse notification (IPN) algorithm on the Apple Watch (Apple Inc., Cupertino, CA) was not designed for use by atrial fibrillation (AF) patients. It is not FDA cleared for use in AF patients. Before this study by Dr. Wasserlauf and colleagues, there were no studies of its accuracy in AF patients. Yet, many AF patients could not resist the temptation to use the feature. In the Apple Heart Study1, even after making it clear that patients with AF were not eligible for the study, 174 (18%) of the participants who received an irregular pulse notification and connected with a study visit doctor confessed that they knew they already had AF and were excluded from the study. These participants were just too curious to pass up the opportunity to see what the new technology was all about.
30 Mar 2023Submitted to Journal of Cardiovascular Electrophysiology
30 Mar 2023Assigned to Editor
30 Mar 2023Submission Checks Completed
30 Mar 2023Review(s) Completed, Editorial Evaluation Pending
30 Mar 2023Editorial Decision: Accept